JNJ

Thought Piece: The Hidden Advantage

by

As activist investing proliferates, investors are becoming more and more familiar with celebrity investing gurus such as Carl Icahn and David Einhorn. Let’s examine how these investing giants have carved out a unique structural advantage over mom-and-pop investors. This article was originally published in June 2014. By Brian Nelson, CFA Wouldn’t it be great to load up on options and then announce to the world that you’ve done so, thereby generating tremendous gains as other investors pile into the stock driving its price higher? I think most investors either believe that such behavior is mere fantasy, or would love to have this significant influence for their own use, assuming it was legal. Perhaps to your surprise, this behavior is neither … Read more

Google, Intel — Yes!

by

Google, Intel — Yes! — Let’s talk Google and Intel, remind you that we’ve removed Chipotle, Xilinx, and Boeing from the newsletter portfolios some time ago. I’ll talk a little about PayPal’s run higher and address some other themes, including contingent liabilities with J&J and 3M. — By Brian Nelson, CFA — We don’t get everything right, of course, but lately, we’ve been really doing a great job getting the right ideas in front of you! I’m super proud of our team at Valuentum, and I hope that you are capitalizing on our research. — In a prior article, I talked about how Facebook (FB) and Visa (V), two top-weighted ideas in the Best Ideas Newsletter portfolio, were on fire … Read more

In the News: Second-Quarter Earnings Season Begins

by

Second-quarter earnings season is upon us. The markets aren’t expecting much growth. Core industrial names may not fare well, but thus far, big pharma is solid. We’re not making any changes to the newsletter portfolios. By Brian Nelson, CFA We’re off to the races with second-quarter earnings season. The markets aren’t expecting much, with the consensus for S&P 500 (SPY) companies to experience a 3% earnings decline, according to FactSet. If this happens, this would mark the first time S&P 500 companies, in aggregate, would have posted year-over-year declines since the first half of 2016. The markets have rallied considerably since then, and despite the strong earnings expansion aided in part by corporate tax cuts, the 12-month forward P/E ratio … Read more

Johnson & Johnson Revises Sales Guidance Higher Yet Again

by

By Callum Turcan Consumer packaged goods and healthcare giant Johnson & Johnson (JNJ), a holding in both our simulated Best Ideas Newsletter and Dividend Growth Newsletter portfolios, reported second-quarter 2019 earnings July 16 that received mixed reviews from the market. Shares of JNJ initially sold off before recovering later in the trading day. Quarterly Highlights Revenue in the period dropped by a tad over 1% year-over-year to $20.6 billion on a GAAP basis, but adjusted operational sales (which exclude foreign currency movements, a headwind to Johnson & Johnson’s second quarter performance, and the net impact of A&D activity) rose by almost 4%. There’s underlying demand growth for Johnson & Johnson’s products, but as with all American companies with significant overseas … Read more

New Highs! The December Call Has Been Well-Rewarded

by

Image shown: Valuentum’s Dividend Growth Newsletter portfolio. Since inception, the newsletter portfolio has *never* had a constituent that experienced a dividend cut. We moved to weighting ranges beginning in 2018.   “The less the prudence with which others conduct their affairs, the greater the prudence with which we must conduct our own.” – Warren Buffett (2018) By Brian Nelson, CFA While others are celebrating, we know better. This market could come down upon itself like nothing else. But for now. We breathe a sigh of relief. A company, Valuentum, that emphasizes the importance of timing and then delivers on that cold December 26 day to move to all-in in the newsletter portfolios is something remarkable (see image below). We cannot go back to … Read more

Markets Swooning, Expect Extreme Volatility, Finger on Put-Option Trigger

by

Image shown: We notified members December 26 that we had  moved  the Best Ideas Newsletter portfolio and Dividend Growth Newsletter portfolio to a “fully invested” position, from a 30% and 20% cash “weighting” at the high end of the range, respectively.  — No change to simulated newsletter portfolios…at this time.  — Hi everyone, — Hope you’re navigating these tumultuous markets well.   — If you recall, during the holiday season last year, we had moved the Best Ideas Newsletter portfolio and Dividend Growth Newsletter portfolio to “fully invested.” See image above (point of the arrow). Because many members were traveling and out of the office, not all were able to read the notification until a week or two after. They were … Read more

J&J Beats Low Expectations, Revises Guidance Upward

by

Image Source: Johnson & Johnson Johnson & Johnson issued updated guidance for 2019 that called for stronger adjusted sales and EPS growth than previously expected, which along with earnings that beat low expectations was enough to send shares up over 1% on the day, April 16. By Callum Turcan Embattled medical giant Johnson & Johnson (JNJ) posted first quarter earnings for 2019, which the market clearly liked as shares of JNJ were bid up by 1.1% on April 16. We include the company in both the simulated Dividend Growth Newsletter portfolio and the simulated Best Ideas Newsletter portfolio. The medical giant is active in the pharmaceuticals, medical device, and packaged consumer goods segments of the healthcare world. As of this … Read more

ATTN: Advisors and Planners — Disruption Is Looming

by

“With the commoditization of investment advice and intense competition from robos and other more cost-efficient solutions, growth-minded advisors want to create bespoke experiences for clients.” — WealthManagement.com By Brian Nelson, CFA Hi Valuentum members, colleagues and friends, Valuentum has a large subscriber base and is one of the most successful paid subscription financial information websites launched this decade. Over the past eight years or so, individuals, financial advisors and money managers from all over the world have subscribed to our services. We pride ourselves on independence and transparency, and we’re a champion of the investor. Today, I’d like to talk directly to our financial advisor, financial planner, and professional money-manager members. You probably already heard the news yesterday: Charles Schwab, which handles … Read more

Outperformance No Matter How You Measure It

by

Image shown: The performance of Valuentum’s simulated Best Ideas Newsletter since the inaugural edition of the newsletter, July 13, 2011. We migrated to a weighting range format for the Best Ideas Newsletter portfolio ideas beginning in 2018. At that time, Visa (V) was the top weighting by far at 8.6%. Shares of Visa have soared since, and other ideas haven’t been too shabby either! Source. Valuentum’s Best Ideas Newsletter portfolio is in a class by itself. Did you know that ~90% of active fund managers are underperforming their benchmarks over prolonged periods of time? The lack of volatility of the simulated Best Ideas Newsletter portfolio had been driven by its massive average cash “weighting” of 25% during its history, something we … Read more

It Definitely Is a *Best* Ideas Newsletter!

by

Image shown: Valuentum migrated to a weighting range format for the Best Ideas Newsletter portfolio ideas beginning in 2018. This article was sent to members via email March 15. By Brian Nelson, CFA I was on social media the other day, and somebody was asking whether there would be more engagement/likes/appreciation from a picture of a cat than if someone were to put up great stock picks year after year. I think the poll came back in favor of the cat pictures! It’s an interesting time, and investors are tuning out great research because they simply don’t know what to listen to. They don’t know the real deal, and that’s why writing Value Trap: Theory of Universal Valuation was so important. It’s … Read more